– Dr. Heikki Lanckriet sole CEO – Peter Llewellyn-Davis proposed for the supervisory board – Pilar de la Huerta to resign from the management board and to transition to the supervisory board Madrid, Spain, and Heidelberg, Germany – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today announced changes to the management team and supervisory board. […]
NEW YORK and HILDEN, Germany – Bristol-Myers Squibb Company (NYSE: BMY) and QIAGEN(NASDAQ: QGEN; Frankfurt Prime Standard: QIA) have signed an agreement to explore the use of next-generation sequencing (NGS) technology to develop gene expression profiles (GEPs) as predictive or prognostic tools for use with Bristol-Myers Squibb novel immuno-oncology (I-O) therapies in cancer treatment. This will […]
Option to add new biomarkers for microsatellite instability (MSI) and mismatch repair (MMR) to QIAGEN’ s NGS panels Hilden, Germany, and Germantown, Maryland – QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced it has received a worldwide license from The Johns Hopkins University for biomarkers that have been shown to play key roles in […]
Agreement Accelerates the Development of Tests to Help Assess Risk of Disease Recurrence in Women with Early-Stage Breast Cancer SANTA CLARA, Calif. & IRVINE, Calif.–Agilent Technologies Inc. (NYSE: A) and Agendia, Inc. today jointly announced an agreement to expand their relationship to include the development of an RNA-Seq kit version of Agendia’s currently marketed MammaPrint […]
Cambridge, UK: Syngene, a world-leading manufacturer of image analysis solutions, today announced its G:BOX Chemi XX6 multi-application imager is being utilised by scientists at a top University in Germany to speed up analysis of genes and proteins associated with neurodegenerative conditions. Researchers at the German University are using a G:BOX Chemi XX6 multi-application imager to […]
Oxford, UK. Oxford Gene Technology (OGT), The Molecular Genetics Company, today announced that it has signed an agreement to be acquired by Sysmex Corporation (Sysmex), a Japanese in vitro diagnostic company. Sysmex will acquire all of OGT’s shares, gaining access to OGT’s genetic analysis technologies and expertise in the cytogenetics domain. OGT will become a […]
PORTLAND, OR and CAMBRIDGE, MA— MolecularMD Corp., a molecular diagnostics company that provides clinical trial services and development of companion diagnostics for targeted and immunotherapies in oncology, is now recognized as a Certified Service Provider of ArcherDX next-generation sequencing (NGS) panels, adding to MolecularMD’s NGS Advanced Diagnostics service offering. The agreement solidifies MolecularMD as a […]
-Expanding Our Portfolio and Reinforcing Our Technology Base in the Life Science Business- Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) has reached an agreement with Oxford Gene Technology IP Limited (HQ: Oxfordshire county, United Kingdom; CEO: Michael Evans; “OGT”) to acquire all shares in OGT (the “Acquisition”). Through this move, Sysmex aims […]
Diverse maize, soybean, wheat, canola and cotton genotypes among those mapped Ness Ziona, Israel – NRGene, the worldwide leader in genomic mapping, assembly, and referencing, has assembled 300 genomes of major crop plants in less than two years, enabling the highly accurate genome comparisons required to breed better seeds. Before NRGene’s technology, individual genomes took years […]
Dr. Kimothy Smith served as Senior Advisor for International Biodefense at Department of Homeland Security’s Office of Health Affairs DELRAY BEACH, Fla. — PositiveID Corporation (OTC:PSIDD), a Life Sciences company focused on detection and diagnostics, announced today its wholly owned subsidiary, ExcitePCR Corporation, has named Dr. Kimothy Smith its Chief Science Officer. Dr. Smith, a recognized […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
